Cargando…
The use of renin angiotensin aldosterone system inhibitors may be associated with decreased mortality after cancer surgery
Renin–angiotensin–aldosterone system (RAAS) inhibitors are antihypertensive agents with conflicting results on protective effects against some types of cancer. In light of these controversies, we aimed to study the effects of RAAS inhibitors in patients undergoing cancer surgery. From March 2010 to...
Autores principales: | Oh, Ah Ran, Park, Jungchan, Lee, Jong-Hwan, Min, Jeong Jin, Gook, Joonhee, Jang, Jae Ni, Lee, Seung-Hwa, Kim, Kyunga, Ahn, Joonghyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046295/ https://www.ncbi.nlm.nih.gov/pubmed/35477724 http://dx.doi.org/10.1038/s41598-022-10759-y |
Ejemplares similares
-
Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea
por: Park, Jungchan, et al.
Publicado: (2021) -
The Charlson Comorbidity Index is associated with risk of 30-day mortality in patients with myocardial injury after non-cardiac surgery
por: Kim, Sojin, et al.
Publicado: (2021) -
Association between high preoperative body mass index and mortality after cancer surgery
por: Park, Jungchan, et al.
Publicado: (2022) -
Association between preoperative neutrophil–lymphocyte ratio and mortality after plastic and reconstructive surgery
por: Sung, Ha Min, et al.
Publicado: (2021) -
Association between Cardiologist Consultation and Mortality of Stable Patients with Elevated Cardiac Troponin at Admission
por: Oh, Ah Ran, et al.
Publicado: (2021)